SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John McCarthy who wrote (236)2/15/1998 10:24:00 AM
From: Manny Gugliuzza  Read Replies (1) of 1510
 
yes-- very good article john-- Message 3436030 this is important and can have several implications that i will look into.

however the removal of these drugs from the market would need some drastic medical side effect and thereby would create a major setback for our approval based on the majority of studies with these combo
drugs. such as if this was the opposite with the fat causing hepatic lipidosis and serious liver disease. these other blood levels of fat can hopefully be controlled unfortunately with more drugs.

it just seems like this combo therapy is digging itself deeper, as more information comes in, not only into a need for remune's saving effects but for the entire treatment of these aids suffering patients
to be reevaluated to the current most effective immune response therapy which is ours.

and believe it or not i think the fda knows this and will move up its approval especially in light of these combo set backs, and in my opinion should be moved up for use by itself also in light of these
combo therapy side effects as it was originally intend for.

all these news item add greatly to the fundamental support of immune response. and although we stalled a little on the takeoff technical support should follow here with consolidation before a move to 12.5 by options expiration.

although the weekly second opinion is lower on the stock they have changed the resistance area to support now at 9and7/8. and also up are the 10 and 20 day moving averages.

ar.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext